Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0R8DO
|
|||
Former ID |
DNC009731
|
|||
Drug Name |
1-Benzyl-4-(4-phenylpiperazin-1-yl)phthalazine
|
|||
Synonyms |
1-Benzyl-4-(4-phenylpiperazin-1-yl)phthalazine; CHEMBL496013; 1-benzyl-4-(4-phenylpiperazino)phthalazine; 320418-04-0; AC1O4EAW; Oprea1_653246; SCHEMBL13444952; KS-000031YH; ZINC1393434; BDBM50269040; AKOS005082019
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C25H24N4
|
|||
Canonical SMILES |
C1CN(CCN1C2=CC=CC=C2)C3=NN=C(C4=CC=CC=C43)CC5=CC=CC=C5
|
|||
InChI |
1S/C25H24N4/c1-3-9-20(10-4-1)19-24-22-13-7-8-14-23(22)25(27-26-24)29-17-15-28(16-18-29)21-11-5-2-6-12-21/h1-14H,15-19H2
|
|||
InChIKey |
PMNLMFUHSIYHHB-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 320418-04-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Smoothened homolog (SMO) | Target Info | Inhibitor | [1] |
KEGG Pathway | Hedgehog signaling pathway | |||
Pathways in cancer | ||||
Proteoglycans in cancer | ||||
Basal cell carcinoma | ||||
Panther Pathway | Hedgehog signaling pathway | |||
Pathway Interaction Database | Signaling events mediated by the Hedgehog family | |||
Hedgehog signaling events mediated by Gli proteins | ||||
Reactome | Class B/2 (Secretin family receptors) | |||
Hedgehog 'off' state | ||||
Activation of SMO | ||||
WikiPathways | Hedgehog Signaling Pathway | |||
Hair Follicle Development: Organogenesis (Part 2 of 3) | ||||
Hair Follicle Development: Induction (Part 1 of 3) | ||||
Integrated Pancreatic Cancer Pathway | ||||
GPCR ligand binding | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | 1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity. J Med Chem. 2009 Jul 9;52(13):3954-68. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.